Senior insider sale
TRANSPHORM, INC. — senior position signals high conviction
$33.9K
7.71K shares
What this filing means
SMALES KELLY plans to sell 7.71K shares of TRANSPHORM, INC. valued at approximately $33.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/5/2024ACC: 0001970051-24-000030
7.71K
Shares to sell
$33.9K
Approx. market value
766.00
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Common Stock
COMPENSATORY PAYMENT
10/11/2023
766.00Total acquired766.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/11/2023 | Common Stock COMPENSATORY PAYMENT | 766.00 | — |
| Total | 766.00 | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
4K
Market value
$19.2K
2/28/2024
—Completed
Units to sell
766.00
Market value
$3.0K
1/4/2024
—Completed
Units to sell
2.19K
Market value
$7.9K
1/2/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
766.00
Market value
$3.8K
4/4/2024
Total
Units
7.71K
Value
$33.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/28/2024 | 4K | $19.2K | — | Completed |
1/4/2024 | 766.00 | $3.0K | — | Completed |
1/2/2024 | 2.19K | $7.9K | — | Completed |
| Planned — Approximate Date | ||||
4/4/2024 | 766.00 | $3.8K | NASDAQ | Planned |
| Total | 7.71K | $33.9K | ||